NeuroBo (NRBO) Lost Nearly 11%, Completed Common Stock Placement
Shan Zee
February 1, 2021
Shares of NeuroBo Pharmaceuticals Inc. (NRBO), a clinical-stage biotechnology company that provides therapies for neurodegenerative and cardiometabolic diseases, dropped by 10.89% on Friday. The company